Target intelligence / Profile preview

RNA, U6 small nuclear 727, pseudogene (RNU6-727P)

Target
RNU6-727P
Molecular classification
Other, Pseudogene, Non-coding RNA
01

Overview

RNU6-727P, also known as RNA, U6 small nuclear 727, pseudogene, is classified as a **pseudogene**—specifically, a non-coding RNA pseudogene in human genomes[1]. It shares sequence similarity with functional U6 small nuclear RNA but, due to mutations or lack of regulatory elements, is typically *non-functional* and does not produce a functional RNA product[2]. U6 snRNAs are core components of the spliceosome involved in pre-mRNA splicing in eukaryotes[7], but RNU6-727P itself is a processed pseudogene and does not participate in these processes[2][3]. Like many pseudogenes, RNU6-727P may theoretically participate in the regulation of gene expression (e.g., acting as a decoy for microRNAs or influencing parental gene regulation via RNA-based mechanisms), but there is no specific functional evidence for RNU6-727P itself[2]. Pseudogenes in general are not considered **therapeutic targets, receptors, enzymes, or transporters**. There are no known drugs, disease biomarkers, or safety concerns associated with this pseudogene[1]. If you are seeking information on the **functional U6 small nuclear RNA** (not the pseudogene), it is an essential snRNA in the spliceosome, but "RNU6-727P" refers strictly to the pseudogene form, which is not a classical drug target nor a molecular entity with known therapeutic modulation[1][2].

Other names
RNU6-727PRNA, U6 small nuclear 727, pseudogene
02

Biological functions

None (no known direct biological function; see description)
03

Disease associations

Other (possible, but no direct role established for RNU6-727P specifically)

Beyond the preview

Go deeper on RNA, U6 small nuclear 727, pseudogene (RNU6-727P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 727, pseudogene (RNU6-727P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call